Please use this identifier to cite or link to this item: https://doi.org/10.1158/1541-7786.MCR-08-0147
Title: Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells
Authors: Ang, E.Z.-F.
Nguyen, H.T.
Sim, H.-L.
Putti, T.C. 
Lim, L.H.K. 
Issue Date: 1-Feb-2009
Citation: Ang, E.Z.-F., Nguyen, H.T., Sim, H.-L., Putti, T.C., Lim, L.H.K. (2009-02-01). Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells. Molecular Cancer Research 7 (2) : 266-274. ScholarBank@NUS Repository. https://doi.org/10.1158/1541-7786.MCR-08-0147
Abstract: Estrogen, a naturally occurring female steroid growth hormone, has been implicated as a major risk factor for the development of breast cancer. Recent research into this disease has also correlated Annexin-1 (ANXA1), a glucocorticoid-inducible protein, with the development of breast tumorigenesis. ANXA1 is lost in many cancers, including breast cancer, and this may result in a functional promotion of tumor growth. In this study, we investigated the expression of ANXA1 in MCF-7 cells treated with estrogen and the regulation of estrogen functions by ANXA1. Exposure of MCF-7 breast cancer cells to high physiologic levels (up to 100 nmol/L) of estrogen leads to an up-regulation of ANXA1 expression partially through the activation of cyclic AMP-responsive element binding protein and dependency on activation of the estrogen receptor. In addition, treatment of MCF-7 cells with physiologic levels of estrogen (1 nmol/L) induced proliferation, whereas high pregnancy levels of estrogen (100 nmol/L) induced a growth arrest of MCF-7 cells, associated with constitutive activation of extracellular signal-regulated kinase 1/2 and up-regulation of cell cycle arrest proteins such as p21 waf/cip. Silencing of ANXA1 with specific small interfering RNA reverses the estrogen-dependent proliferation as well as growth arrest and concomitantly modulates extracellular signal-regulated kinase 1/2 phosphorylation. We confirm that ANXA1 is lost in clinical breast cancer, indicating that the antiproliferative protective function of ANXA1 against high levels of estrogen may be lost. Finally, we show that ANXA1-deficient mice exhibit faster carcinogen-induced tumor growth. Our data suggest that ANXA1 may act as a tumor suppressor gene and modulate the proliferative functions of estrogens. Copyright © 2009 American Association for Cancer Research.
Source Title: Molecular Cancer Research
URI: http://scholarbank.nus.edu.sg/handle/10635/107465
ISSN: 15417786
DOI: 10.1158/1541-7786.MCR-08-0147
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

34
checked on Oct 12, 2018

WEB OF SCIENCETM
Citations

37
checked on Oct 2, 2018

Page view(s)

68
checked on Oct 12, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.